Live feed
·
PRReleasevia Quantisnow
Xeris Biopharma Holdings Inc. logo

Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance

ByQuantisnow·Wall Street's wire, on your screen.
XERS· Xeris Biopharma Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XERS (Xeris Biopharma Holdings Inc.) and more on Quantisnow.